Cargando…
BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters
BACKGROUND: BRAF mutations are a common finding in malignant melanoma (MM). Nevertheless, apart from their significance as a therapeutic target in advanced melanoma, their prognostic value is still debated. OBJECTIVE: To assess BRAF mutation status in primary, recurrent, or metastatic MM and its cor...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Derm101.com
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368075/ https://www.ncbi.nlm.nih.gov/pubmed/30775150 http://dx.doi.org/10.5826/dpc.0901a13 |
_version_ | 1783393921079967744 |
---|---|
author | Spathis, Aris Katoulis, Alexander C. Damaskou, Vasileia Liakou, Aikaterini I. Kottaridi, Christine Leventakou, Danai Sgouros, Dimitrios Mamantopoulos, Andreas Rigopoulos, Dimitrios Karakitsos, Petros Panayiotides, Ioannis G. |
author_facet | Spathis, Aris Katoulis, Alexander C. Damaskou, Vasileia Liakou, Aikaterini I. Kottaridi, Christine Leventakou, Danai Sgouros, Dimitrios Mamantopoulos, Andreas Rigopoulos, Dimitrios Karakitsos, Petros Panayiotides, Ioannis G. |
author_sort | Spathis, Aris |
collection | PubMed |
description | BACKGROUND: BRAF mutations are a common finding in malignant melanoma (MM). Nevertheless, apart from their significance as a therapeutic target in advanced melanoma, their prognostic value is still debated. OBJECTIVE: To assess BRAF mutation status in primary, recurrent, or metastatic MM and its correlations with histopathological findings. METHODS: We analyzed 203 samples from 178 consecutive patients: 129 primary cutaneous MM, 49 metastatic and recurrent MM of unknown primary site, and 25 cases of recurrences or metastases of primary MM. BRAF mutations in exon 15 were identified with real-time polymerase chain reaction and/or direct sequencing or pyrosequencing. Histopathological examination was performed according to standard procedures. RESULTS: We observed a 42.1% prevalence of BRAF mutations at codon 600 among our patients, 84% of whom harbored the V600E mutation. Mutations showed a statistically significant increase in younger patients (P = 0.011), in ulcerated tumors (P = 0.020), and in tumors lacking solar elastosis in adjacent dermis (P = 0.008). Mutations were also more common in male patients, as well as in primary MMs of the torso, and in nonvisceral metastases, however without reaching statistical significance. Logistic regression analysis identified type and ulceration as the only significant predictors of BRAF mutation. The highest frequencies of mutated BRAF were identified in superficial spreading and nodular types, and the lowest in acral lentiginous and lentigo maligna types. In situ MM and primary dermal melanoma displayed intermediate frequencies. CONCLUSION: Frequency of mutated BRAF is type-related and correlated with ulceration, a known adverse prognostic factor. |
format | Online Article Text |
id | pubmed-6368075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Derm101.com |
record_format | MEDLINE/PubMed |
spelling | pubmed-63680752019-02-15 BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters Spathis, Aris Katoulis, Alexander C. Damaskou, Vasileia Liakou, Aikaterini I. Kottaridi, Christine Leventakou, Danai Sgouros, Dimitrios Mamantopoulos, Andreas Rigopoulos, Dimitrios Karakitsos, Petros Panayiotides, Ioannis G. Dermatol Pract Concept Articles BACKGROUND: BRAF mutations are a common finding in malignant melanoma (MM). Nevertheless, apart from their significance as a therapeutic target in advanced melanoma, their prognostic value is still debated. OBJECTIVE: To assess BRAF mutation status in primary, recurrent, or metastatic MM and its correlations with histopathological findings. METHODS: We analyzed 203 samples from 178 consecutive patients: 129 primary cutaneous MM, 49 metastatic and recurrent MM of unknown primary site, and 25 cases of recurrences or metastases of primary MM. BRAF mutations in exon 15 were identified with real-time polymerase chain reaction and/or direct sequencing or pyrosequencing. Histopathological examination was performed according to standard procedures. RESULTS: We observed a 42.1% prevalence of BRAF mutations at codon 600 among our patients, 84% of whom harbored the V600E mutation. Mutations showed a statistically significant increase in younger patients (P = 0.011), in ulcerated tumors (P = 0.020), and in tumors lacking solar elastosis in adjacent dermis (P = 0.008). Mutations were also more common in male patients, as well as in primary MMs of the torso, and in nonvisceral metastases, however without reaching statistical significance. Logistic regression analysis identified type and ulceration as the only significant predictors of BRAF mutation. The highest frequencies of mutated BRAF were identified in superficial spreading and nodular types, and the lowest in acral lentiginous and lentigo maligna types. In situ MM and primary dermal melanoma displayed intermediate frequencies. CONCLUSION: Frequency of mutated BRAF is type-related and correlated with ulceration, a known adverse prognostic factor. Derm101.com 2019-01-31 /pmc/articles/PMC6368075/ /pubmed/30775150 http://dx.doi.org/10.5826/dpc.0901a13 Text en ©2019 Spathis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Articles Spathis, Aris Katoulis, Alexander C. Damaskou, Vasileia Liakou, Aikaterini I. Kottaridi, Christine Leventakou, Danai Sgouros, Dimitrios Mamantopoulos, Andreas Rigopoulos, Dimitrios Karakitsos, Petros Panayiotides, Ioannis G. BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters |
title | BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters |
title_full | BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters |
title_fullStr | BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters |
title_full_unstemmed | BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters |
title_short | BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters |
title_sort | braf mutation status in primary, recurrent, and metastatic malignant melanoma and its relation to histopathological parameters |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368075/ https://www.ncbi.nlm.nih.gov/pubmed/30775150 http://dx.doi.org/10.5826/dpc.0901a13 |
work_keys_str_mv | AT spathisaris brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT katoulisalexanderc brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT damaskouvasileia brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT liakouaikaterinii brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT kottaridichristine brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT leventakoudanai brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT sgourosdimitrios brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT mamantopoulosandreas brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT rigopoulosdimitrios brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT karakitsospetros brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters AT panayiotidesioannisg brafmutationstatusinprimaryrecurrentandmetastaticmalignantmelanomaanditsrelationtohistopathologicalparameters |